Standout Papers
Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Genome sequence of an industrial microorganism Streptomyces avermitilis : Deducing the ability of producing secondary metabolites
2001 StandoutNobel
Cancer in Africa 2012
2014
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
2012
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles
2012
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
2007
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Risk and Predictors of Mortality Associated With Chronic Hepatitis B Infection
2007
Hepatitis C Virus Infection
2001 Standout
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Control of Hepatitis B Virus Replication by Innate Response of Heparg Cells
2009
Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and Genotypes A, B, C, D, and F
2007
Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach
2014
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment
2013
Diagnostic tests for hepatitis C
1999
Hepatitis B: Reflections on the current approach to antiviral therapy
2008
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Regulation of hepatic innate immunity by hepatitis C virus
2013
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
2006
Nonprimate Hepaciviruses in Domestic Horses, United Kingdom
2012
Virus-like particles in vaccine development
2010
A CRISPR toolbox to study virus–host interactions
2017
Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
2011
Hepatitis B virus infection
2009 Standout
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study
2007
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
2006
The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding
2002
Thiol Template Peptide Synthesis Systems in Bacteria and Fungi
1996
Non-Hodgkin's lymphomas in Alexandria, Egypt; incidence rates and trend study (1995–2004)
2007
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Global cancer statistics
2011 Standout
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
2011
HCV transmission in industrialized countries and resource-constrained areas
2013
Global epidemiology and burden of hepatitis C
2002
Distinct Regions of Human eIF3 Are Sufficient for Binding to the HCV IRES and the 40S Ribosomal Subunit
2010
Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies
2007
Chronic hepatitis B
2007 Standout
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Hepatitis C Virus Subverts Liver-Specific miR-122 to Protect the Viral Genome from Exoribonuclease Xrn2
2014
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
2012
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
2006
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis
2009
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies
2007
The Human Plasma Proteome
2002 Standout
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
2006
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Developmental Regulation of Hepatitis B Virus Biosynthesis by Hepatocyte Nuclear Factor 4α
2009
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
The B-cell receptor of a hepatitis C virus (HCV)–associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis
2001
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens
2016 Nature
Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis
2013
Genetic History of Hepatitis C Virus in East Asia
2008
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
2010
Prevention of materno‐foetal transmission of hepatitis B in sub‐Saharan Africa: the evidence, current practice and future challenges
2014
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein
2009 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Spring-Loaded Mechanism of DNA Unwinding by Hepatitis C Virus NS3 Helicase
2007 Science
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Modeling hepatitis C virus infection using human induced pluripotent stem cells
2012 StandoutNobel
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization
2008
Health‐related quality of life in chronic hepatitis B patients†
2008
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
Efficient Initiation of HCV RNA Replication in Cell Culture
2000 StandoutScienceNobel
Genetic diversity and evolution of hepatitis C virus – 15 years on
2004
Regulation of Hepatitis C Virus Replication by Nuclear Translocation of Nonstructural 5A Protein and Transcriptional Activation of Host Genes
2013
Hyperphosphorylation of the Hepatitis C Virus NS5A Protein Requires an Active NS3 Protease, NS4A, NS4B, and NS5A Encoded on the Same Polyprotein
1999
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Replication of Subgenomic Hepatitis C Virus Replicons in Mouse Fibroblasts Is Facilitated by Deletion of Interferon Regulatory Factor 3 and Expression of Liver-Specific MicroRNA 122
2010
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Virus‐neutralizing antibodies to hepatitis C virus
2013
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
2012 Standout
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3)
2011 StandoutNobel
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt
2010
Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding
2006
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Flaviviridae Replication Organelles: Oh, What a Tangled Web We Weave
2015
Chemical Glycoproteomics
2016 StandoutNobel
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Works of Daniel Lavanchy being referenced
The global burden of hepatitis C
2009
Evolving epidemiology of hepatitis C virus
2010
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
2005
Hepatitis C: public health strategies
1999
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Immunogenicity of a recombinant pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster
1994
Evaluation of a new automated third-generation anti-HCV enzyme immunoassay
1996
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus
2010
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
2005
High prevalence of hepatitis C virus among urban and rural population groups in Egypt
1995
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.
1999
Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
1999
Monoclonal Antibodies to the Multienzyme Enniatin Synthetase. Production and Use in Structural Studies
1987
Microheterogeneity of Serum Glycoproteins in Patients with Chronic Alcohol Abuse Compared with Carbohydrate-deficient Glycoprotein Syndrome Type I
1999
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
2000